Söndag 22 December | 02:23:09 Europe / Stockholm

Bifogade filer

Kalender

Tid*
2025-04-22 N/A Årsstämma
2025-01-28 08:00 Bokslutskommuniké 2024
2024-10-18 - Kvartalsrapport 2024-Q3
2024-07-18 - Kvartalsrapport 2024-Q2
2024-04-23 - X-dag ordinarie utdelning GETI B 4.40 SEK
2024-04-22 - Årsstämma
2024-04-22 - Kvartalsrapport 2024-Q1
2024-02-01 - Bokslutskommuniké 2023
2023-10-23 - Kvartalsrapport 2023-Q3
2023-07-18 - Kvartalsrapport 2023-Q2
2023-04-27 - X-dag ordinarie utdelning GETI B 4.25 SEK
2023-04-26 - Årsstämma
2023-04-26 - Kvartalsrapport 2023-Q1
2023-02-01 - Bokslutskommuniké 2022
2022-10-19 - Kvartalsrapport 2022-Q3
2022-07-19 - Kvartalsrapport 2022-Q2
2022-04-27 - X-dag ordinarie utdelning GETI B 4.00 SEK
2022-04-26 - Årsstämma
2022-04-26 - Kvartalsrapport 2022-Q1
2022-01-28 - Bokslutskommuniké 2021
2021-10-20 - Kvartalsrapport 2021-Q3
2021-07-16 - Kvartalsrapport 2021-Q2
2021-04-21 - X-dag ordinarie utdelning GETI B 3.00 SEK
2021-04-20 - Årsstämma
2021-04-20 - Kvartalsrapport 2021-Q1
2021-01-28 - Bokslutskommuniké 2020
2020-10-16 - Kvartalsrapport 2020-Q3
2020-07-16 - Kvartalsrapport 2020-Q2
2020-06-29 - X-dag ordinarie utdelning GETI B 1.50 SEK
2020-06-26 - Årsstämma
2020-04-22 - Kvartalsrapport 2020-Q1
2020-01-30 - Bokslutskommuniké 2019
2019-10-18 - Kvartalsrapport 2019-Q3
2019-07-17 - Kvartalsrapport 2019-Q2
2019-04-24 - X-dag ordinarie utdelning GETI B 1.00 SEK
2019-04-23 - Årsstämma
2019-04-23 - Kvartalsrapport 2019-Q1
2019-01-30 - Bokslutskommuniké 2018
2018-10-18 - Kvartalsrapport 2018-Q3
2018-07-17 - Kvartalsrapport 2018-Q2
2018-04-27 - X-dag ordinarie utdelning GETI B 1.50 SEK
2018-04-26 - Årsstämma
2018-04-26 - Kvartalsrapport 2018-Q1
2018-01-29 - Bokslutskommuniké 2017
2017-10-18 - Kvartalsrapport 2017-Q3
2017-07-17 - Kvartalsrapport 2017-Q2
2017-04-25 - Kvartalsrapport 2017-Q1
2017-03-30 - X-dag ordinarie utdelning GETI B 2.00 SEK
2017-03-29 - Årsstämma
2017-01-26 - Bokslutskommuniké 2016
2016-10-18 - Kvartalsrapport 2016-Q3
2016-07-14 - Kvartalsrapport 2016-Q2
2016-04-22 - Kvartalsrapport 2016-Q1
2016-03-31 - X-dag ordinarie utdelning
2016-03-30 - Årsstämma
2016-01-28 - Bokslutskommuniké 2015
2015-10-15 - Kvartalsrapport 2015-Q3
2015-09-02 - Extra Bolagsstämma 2015
2015-07-15 - Kvartalsrapport 2015-Q2
2015-04-20 - Kvartalsrapport 2015-Q1
2015-03-26 - X-dag ordinarie utdelning GETI B 2.80 SEK
2015-03-25 - Årsstämma
2015-01-28 - Bokslutskommuniké 2014
2014-10-16 - Kvartalsrapport 2014-Q3
2014-10-16 - Analytiker möte 2014
2014-07-15 - Kvartalsrapport 2014-Q2
2014-04-16 - Kvartalsrapport 2014-Q1
2014-03-21 - X-dag ordinarie utdelning GETI B 4.15 SEK
2014-03-20 - Årsstämma
2014-01-28 - Bokslutskommuniké 2013
2013-10-15 - Kvartalsrapport 2013-Q3
2013-10-15 - Analytiker möte 2013
2013-10-15 - 15-7 2013
2013-07-11 - Kvartalsrapport 2013-Q2
2013-04-17 - Kvartalsrapport 2013-Q1
2013-03-22 - X-dag ordinarie utdelning GETI B 4.15 SEK
2013-03-21 - Årsstämma
2013-02-08 - Kapitalmarknadsdag 2013
2013-01-25 - Bokslutskommuniké 2012
2012-10-17 - Kvartalsrapport 2012-Q3
2012-10-17 - Analytiker möte 2012
2012-07-11 - Kvartalsrapport 2012-Q2
2012-04-19 - Kvartalsrapport 2012-Q1
2012-03-29 - X-dag ordinarie utdelning GETI B 3.75 SEK
2012-03-28 - Årsstämma
2012-01-26 - Bokslutskommuniké 2011
2011-10-20 - Kvartalsrapport 2011-Q3
2011-07-11 - Kvartalsrapport 2011-Q2
2011-04-28 - X-dag ordinarie utdelning GETI B 3.25 SEK
2011-04-27 - Årsstämma
2011-04-27 - Kvartalsrapport 2011-Q1
2011-01-28 - Kapitalmarknadsdag 2011
2011-01-26 - Bokslutskommuniké 2010
2010-10-19 - Kvartalsrapport 2010-Q3
2010-04-23 - X-dag ordinarie utdelning GETI B 2.75 SEK
2010-04-22 - X-dag ordinarie utdelning GETI B 2.75 SEK
2010-04-21 - Årsstämma
2010-04-21 - Kvartalsrapport 2010-Q1
2010-01-26 - Bokslutskommuniké 2009
2009-07-13 - Kvartalsrapport 2009-Q2
2009-05-06 - Kvartalsrapport 2009-Q3
2009-04-22 - X-dag ordinarie utdelning GETI B 2.40 SEK
2009-04-21 - Årsstämma
2009-04-21 - Kvartalsrapport 2009-Q1
2008-04-18 - X-dag ordinarie utdelning GETI B 2.40 SEK
2007-04-20 - X-dag ordinarie utdelning GETI B 2.20 SEK
2006-04-21 - X-dag ordinarie utdelning GETI B 2.00 SEK
2005-04-20 - X-dag ordinarie utdelning GETI B 1.65 SEK
2004-04-22 - X-dag ordinarie utdelning GETI B 1.35 SEK
2003-11-25 - Split GETI B 1:4
2003-04-24 - X-dag ordinarie utdelning GETI B 4.25 SEK
2002-04-19 - X-dag ordinarie utdelning GETI B 3.75 SEK
2001-04-24 - X-dag ordinarie utdelning GETI B 3.50 SEK
2000-04-28 - X-dag ordinarie utdelning GETI B 3.50 SEK
1999-04-22 - X-dag ordinarie utdelning GETI B 3.25 SEK
1998-04-24 - X-dag ordinarie utdelning GETI B 2.75 SEK
1997-04-30 - X-dag ordinarie utdelning GETI B 2.50 SEK
1996-04-19 - X-dag ordinarie utdelning GETI B 6.00 SEK

Beskrivning

LandSverige
ListaLarge Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Getinge är ett globalt medicintekniskt bolag som specialiserar sig på att tillhandahålla utrustning och IT-system till hälso- och sjukvården samt life science-industrin. Bolaget erbjuder bland annat lösningar för operationssalar, intensivvårdsavdelningar, steriliseringscentraler och läkemedelsutveckling. Bolaget grundades år 1904 och har sitt huvudkontor i Göteborg.
2024-09-25 16:07:00

The notified body, TÜV SÜD, reinstates Getinge's CE certificate for HLS and PLS consumables, used for ECLS therapy, with certain conditions. Temporary challenges with a supplier and production changeover related to the new packaging solution have resulted in a lower volume of HLS and PLS sets available for shipment in Q3 2024, which is expected to be phased into Q4 2024.

In March 2023, Getinge's CE certificate for the consumables HLS and PLS sets used for extracorporeal life support (ECLS) was suspended due to a potential defect in the sterile packaging. However, under the exemption provided by EU MDR Article 59, sales have still been able to continue to countries that require CE certification.

As previously communicated by Getinge, a new packaging solution has been developed, and an application for CE approval was submitted to the notified body TÜV SÜD in Q2 2024. TÜV SÜD has now evaluated Getinge's application and decided to reinstate the CE certificate, with certain conditions to be fulfilled. Getinge expects to regain deliveries of mentioned products in Q4 2024.

The reinstatement of the CE certificate is a result of committed work and a close and constructive dialogue between Getinge and TÜV SÜD. However, quality problems with deliveries from a key supplier and production changeover related to the new packaging solution, have resulted in a lower volume of HLS and PLS sets available for shipment in Q3 2024, which is expected to be phased into Q4 2024.

"We are aware of the very problematic situation this product shortage puts healthcare professionals and critically ill patients in. Therefore, we are working urgently and in close dialogue with our customers to minimize the impact," says Elin Frostehav, President Acute Care Therapies at Getinge.

TÜV SÜD has also announced that the temporary suspension of Getinge's Cardiosave Intra-Aortic Balloon Pump, effective from March 2024, will be extended until July 1, 2025. This decision does not affect the already installed base of Cardiosave. This means that products already on the market can continue to be used. Consumables, service, and spare parts for the pumps are not affected. The decision is not deemed to be financially material for Getinge.

Contact information:

Lars Mattsson, SVP Corporate Development (Corporate Strategy, M&A and IR) 
Phone: +46 (0)10 335 0043
Email: lars.mattsson@getinge.com

David Kördel, Head of Investor Relations
Phone: +46 (0)10 335 0077
Email: david.kordel@getinge.com

Caroline Örmgård, Head of Public & Media Relations
Phone: +46 (0)10 335 0041
Email: caroline.ormgard@getinge.com

About Getinge
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions that aim to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs approximately 12,000 people worldwide and the products are sold in more than 135 countries.